Immunotherapy and Targeted Therapies in Skin Cancer

The development of immunotherapy and targeted treatment has significantly expanded options for advanced skin cancers. This topic will explore immune checkpoint inhibitors and molecularly targeted therapies. Participants will examine treatment strategies for advanced melanoma and selected non-melanoma skin cancers. The importance of tumour biology and molecular profiling in treatment selection will be discussed. Potential treatment responses, resistance mechanisms, and adverse effects will also be reviewed. Combination treatment strategies represent an important area of ongoing research. Personalized oncology and precision dermatology are creating new opportunities for individualized treatment. Future therapeutic approaches aimed at improving durable responses will also be considered.

  • Immune Checkpoint Inhibitors
  • Molecularly Targeted Therapies
  • Treatment Resistance and Combination Therapies

    Related Conference of Immunotherapy and Targeted Therapies in Skin Cancer

    August 25-26, 2026

    26th European Dermatology Congress

    Paris, France
    September 23-24, 2026

    9th International Dermatology Conference: Skin and Body

    Barcelona, Spain
    October 27-28, 2026

    20th International Conference on Alzheimers Disease & Dementia

    Amsterdam, Netherlands
    December 03-04, 2026

    9th World Cosmetic and Dermatology Congress

    Madrid, Spain
    December 03-04, 2026

    28th World Dermatology and Aesthetic Congress

    Madrid, Spain
    March 29-30, 2027

    28th World Dermatology Congress

    Paris, France

    Immunotherapy and Targeted Therapies in Skin Cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in